MR Conditional Physician Resources for GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface*,†Instructions for UseMRI Safety InformationImage Overview Specifications Resources Clinical Data Case Studies Value Summary Explore our resourcesSortA -> ZZ -> AOldestNewestSort A -> ZZ -> AOldestNewestResource TypeNewsletterClinical DataComparisonFeatures and BenefitsNewsResource Type NewsletterClinical DataComparisonFeatures and BenefitsNews SuperB Flyer - EMEA, Canada, and Australia / New Zealand GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface See more Mechanical Properties Brochure GORE® VIABAHN® Endoprosthesis See more Peripheral Vision VEITH Special Edition 2011 Conformable GORE® TAG® Thoracic Endoprosthesis, GORE® Hybrid Vascular Graft, GORE® PROPATEN See more Gore REVISE Clinical Study Brochure Gore REVISE Clinical Study outcomes with a focus on reducing reinterventions, lower costs and See more AV Access 6-month PMS Data Flyer Data flyer to support the 6-month AV Access PMS outcomes after treatment of a stenosed or See more Data-Driven Solutions to Optimize Arteriovenous (AV) Access Maintenance Outcomes KDOQI Aligned Outcomes flyer to support the PTA limitation campaign for GORE® VIABAHN® See more 5-year PMS Data Brochure Gore Japan 5-year post-market clinical study results including primary patency, secondary See more AV Access 1-year PMS Data Flyer Data flyer to support the 1-year AV Access PMS outcomes after treatment of a stenosed or See more Press Release EMEA launch: GORE® VIABAHN® Endoprosthesis: Large diameter configurations with lower delivery profile A press release highlighting the continued innovation of large diameter configurations with See more 1-year Japan Post Market Clinical Study Brochure Gore Japan Post Market Clinical Study: Proven patency in challenging disease at one year; Japan See more MRI Conditional Products Flyer The tables show the Gore devices that are labeled as MR conditional. This means that the devices See more AV Access 6-month PMS Data Flyer Data flyer to support the 6-month AV Access PMS outcomes after treatment of a stenosed or See more Load More Top
SuperB Flyer - EMEA, Canada, and Australia / New Zealand GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface See more
Peripheral Vision VEITH Special Edition 2011 Conformable GORE® TAG® Thoracic Endoprosthesis, GORE® Hybrid Vascular Graft, GORE® PROPATEN See more
Gore REVISE Clinical Study Brochure Gore REVISE Clinical Study outcomes with a focus on reducing reinterventions, lower costs and See more
AV Access 6-month PMS Data Flyer Data flyer to support the 6-month AV Access PMS outcomes after treatment of a stenosed or See more
Data-Driven Solutions to Optimize Arteriovenous (AV) Access Maintenance Outcomes KDOQI Aligned Outcomes flyer to support the PTA limitation campaign for GORE® VIABAHN® See more
5-year PMS Data Brochure Gore Japan 5-year post-market clinical study results including primary patency, secondary See more
AV Access 1-year PMS Data Flyer Data flyer to support the 1-year AV Access PMS outcomes after treatment of a stenosed or See more
Press Release EMEA launch: GORE® VIABAHN® Endoprosthesis: Large diameter configurations with lower delivery profile A press release highlighting the continued innovation of large diameter configurations with See more
1-year Japan Post Market Clinical Study Brochure Gore Japan Post Market Clinical Study: Proven patency in challenging disease at one year; Japan See more
MRI Conditional Products Flyer The tables show the Gore devices that are labeled as MR conditional. This means that the devices See more
AV Access 6-month PMS Data Flyer Data flyer to support the 6-month AV Access PMS outcomes after treatment of a stenosed or See more
